These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3504239)

  • 1. Parkinsonism following dystonia in three patients.
    Katchen M; Duvoisin RC
    Mov Disord; 1986; 1(2):151-7. PubMed ID: 3504239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
    Klawans HL; Paleologos N
    Clin Neuropharmacol; 1986; 9(3):298-302. PubMed ID: 3719575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dystonia preceding dopa-responsive parkinsonism--heterogeneous clinical features].
    Miwa H; Mizuno Y
    No To Shinkei; 1996 Feb; 48(2):149-54. PubMed ID: 8865694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to assess motor impairment in writer's cramp.
    Zeuner KE; Peller M; Knutzen A; Holler I; Münchau A; Hallett M; Deuschl G; Siebner HR
    Mov Disord; 2007 Jun; 22(8):1102-9. PubMed ID: 17230462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.
    Furukawa Y; Mizuno Y; Narabayashi H
    Adv Neurol; 1996; 69():327-37. PubMed ID: 8615147
    [No Abstract]   [Full Text] [Related]  

  • 6. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystonia in untreated parkinsonism.
    LeWitt PA; Burns RS; Newman RP
    Clin Neuropharmacol; 1986; 9(3):293-7. PubMed ID: 3719574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystonia in Parkinson's disease: clinical and pharmacological features.
    Poewe WH; Lees AJ; Stern GM
    Ann Neurol; 1988 Jan; 23(1):73-8. PubMed ID: 3345068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is levodopa toxic to human substantia nigra?
    Rajput AH; Fenton Me; Birdi S; Macaulay R
    Mov Disord; 1997 Sep; 12(5):634-8. PubMed ID: 9380042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex dystonia of Parkinson's disease: clinical features and relation to plasma levodopa profile.
    McHale DM; Sage JI; Sonsalla PK; Vitagliano D
    Clin Neuropharmacol; 1990 Apr; 13(2):164-70. PubMed ID: 2328507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A family with hereditary juvenile dystonia-parkinsonism.
    Ishikawa A; Miyatake T
    Mov Disord; 1995 Jul; 10(4):482-8. PubMed ID: 7565830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic fluctuating dystonia: a case of foot dystonia and writer's cramp responsive to L-dopa.
    Deonna T; Ferreira A
    Dev Med Child Neurol; 1985 Dec; 27(6):819-21. PubMed ID: 4092856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Writer's cramp--focal dystonia or psychogenic movement disorder? A critical literature study].
    Zacher A
    Fortschr Neurol Psychiatr; 1989 Aug; 57(8):328-36. PubMed ID: 2676808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early morning dystonia: a complication of levodopa therapy in Parkinson disease. Presentation of 4 cases].
    Molina Arjona JA; Arnal García C; Calandre Hoenigsfeld L; Bermejo Pareja F
    Med Clin (Barc); 1984 Jun; 83(2):47-9. PubMed ID: 6471944
    [No Abstract]   [Full Text] [Related]  

  • 15. Individual manifestations of Parkinson's disease after ten or more years of levodopa.
    Klawans HL
    Mov Disord; 1986; 1(3):187-92. PubMed ID: 3504244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young onset Parkinson's disease.
    Quinn N; Critchley P; Marsden CD
    Mov Disord; 1987; 2(2):73-91. PubMed ID: 3504266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal inhibition in writer's cramp.
    Chen RS; Tsai CH; Lu CS
    Mov Disord; 1995 Sep; 10(5):556-61. PubMed ID: 8552105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced motor complications in dopa-responsive dystonia: implications for the pathogenesis of dyskinesias and motor fluctuations.
    de la Fuente-Fernández R
    Clin Neuropharmacol; 1999; 22(4):216-9. PubMed ID: 10442251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A family of parkinsonism in which the clinical feature of constituents varied with the age of onset].
    Sasaki R; Kuzuhara S; Taniguchi A; Narita Y; Naito Y
    Rinsho Shinkeigaku; 1994 Jul; 34(7):736-8. PubMed ID: 7955737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single family with writer's cramp, essential tremor, and primary writing tremor.
    Cohen LG; Hallett M; Sudarsky L
    Mov Disord; 1987; 2(2):109-16. PubMed ID: 3504263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.